Skip to main content

Table 1 Demographic features of the study population

From: Clinical outcomes of submassive pulmonary embolism thrombolysis—an Indian experience

  Control group, n = 44 Thrombolysis group, n = 42 p value*
Sex Male 24 (54.5) 29 (69) 0.167
Female 20 (45.5) 13 (31)
Age, mean ± SD (range) 63.3 ± 14.7 (28–86) 56.4 ± 13.8 (20–69) 0.001
Weight, mean ± SD (range) 73.5 ± 11.6 (40–96) 55 ± 16.5 (16–86) 0.611
Comorbidities COPD 4 (9.1) 3 (7.1) 0.741
CCF (RHF) 5 (11.4) 12 (28.6) 0.045
Previous PTE 0 (0) 1 (2.4) 0.303
Active cancer 4 (9.1) 3 (7.1) 0.741
Surgery and major trauma 1 (2.3) 6 (14.3) 0.042
Pregnancy 0 (0) 1 (2.4) 0.303
Immobilization 2 (4.5) 4 (9.5) 0.365
Estrogen use 1 (2.3) 2 (4.8) 0.529
DVT 5 (11.4) 4 (9.5) 0.781
  1. *p value < 0.05, statistically significant. COPD chronic obstructive pulmonary disease, CCF congestive cardiac failure, DVT deep venous thrombosis